As the calendar turns to October, the FDA hopes to help physicians prepare for Breast Cancer Awareness Month by offering resources to educate patients on mammography.

Following World Alzheimer's Day, a list of recent Alzheimer's studies, including brain PET research, was recently published by Examiner.com.

Acorda Therapeutics has made an agreement with Civitas Therapeutics to acquire the latter for $525 million. The purchase comes with global rights over a portfolio of drugs in development, including an inhalable drug called CVT-301, currently being validated for the treatment of Parkinson’s disease symptoms, Acorda announced Sept. 24.

Navidea Biopharmaceuticals announced Friday that the Committee for Medicinal Products for Human Use (CHMP), a division of the European Medicines Agency (EMA), is recommending marketing authorization in the European Union for Lymphoseek (tilmanocept) preparation for the presurgical mapping of sentinel lymph nodes that provide a point of potential metastasis in primary head and beck oral cavity squamous cell carcinoma, melanoma and breast cancer.

Altruistic people, such as those who would be willing to donate an organ to a stranger, show a stronger response to fearful faces in the form of a spike of activity in the amygdala when scanned using fMRI, according to a feature in the Discover D-Brief Blog.

A retrospective study gauging the benefit of PET/CT after first-line therapy for follicular lymphoma in multi-center trials puts PET/CT on a pedestal above CT alone as a tool for gauging patients’ response to therapy and prospective survival, according to a study published Sept. 18 in The Lancet Haematology.

Monitoring dopamine activity may not be as ideal as previously thought for patients suspected of having Parkinson’s disease. Researchers at Washington State University have found an “imposter molecule” that could be mistaken for dopamine in tests that look for low-levels of the neurostransmitter as a sign of the neurodegenerative disease, the university announced Wednesday.

Ultrasound is an attractive imaging option due to the absence of ionizing radiation and low cost relative to other modalities. Because of this, researchers have been investigating ultrasound as a superior alternative for a number of indications, and this week’s top stories were dominated by these efforts.